Napapon Sailasuta1, Jintanat Ananworanich, Sukalaya Lerdlum, Pasiri Sithinamsuwan, James L K Fletcher, Somporn Tipsuk, Mantana Pothisri, Tanate Jadwattanakul, Supunnee Jirajariyavej, Thep Chalermchai, Stephanie Catella, Edgar Busovaca, Akash Desai, Robert Paul, Victor Valcour. 1. *Department of Tropical Medicine, University of Hawaii, Honolulu, HI;†U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD;‡Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD;§SEARCH, Thai Red Cross AIDS Research Center, Bangkok, Thailand;‖Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;¶Division of Neurology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand;#Queen Savang Vadhana Memorial Hospital, Chomburi, Thailand;**Taksin Hospital, Bangkok, Thailand;††Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA; and‡‡Department of Psychology, Missouri Institute of Mental Health, University of Missouri, St. Louis, MO.
Abstract
OBJECTIVE: Combination antiretroviral therapy (cART) can suppress plasma HIV RNA to undetectable levels; yet reports indicate persistent HIV-associated neurocognitive disorders (HAND) among treated individuals. We sought to investigate imaging correlates of incomplete cognitive recovery among individuals with chronic HIV. METHODS: We used single voxel proton magnetic resonance spectroscopy in 4 regions of the brain to measure changes in neuronal and glia biomarkers in cART-naive subjects before (n = 59, 27 with HAND) and after 12 months of cART. RESULTS: At baseline, we observed elevated total choline (CHO) in the basal ganglia (BG, P = 0.002) and in the posterior cingulate gyrus (PCG, P = 0.022) associated with HIV infection. Myo-inositol (MI) was elevated in the frontal white matter (FWM, P = 0.040). N-acetylaspartate was elevated in the BG (P = 0.047). Using a mixed model approach among all HIV-infected individuals, at 6 months, we observed decreased n- acetylaspartate in FWM (P = 0.031), decreased creatine in PCG (P = 0.026) and increased MI in frontal gray matter (FGM, P = 0.023). At 12 months, we observed an increase in BG MI (P = 0.038) and in FGM (P = 0.021). Compared to those with normal cognition, HAND cases had higher FGM MI (P = 0.014) at baseline. At 12 months, individuals that remained cognitively impaired compared with those without HAND exhibited elevated CHO in the PCG (P = 0.018) and decreased glutamate in both FWM (P = 0.027) and BG (P = 0.013). CONCLUSIONS: cART started during chronic HIV is associated with reduced neuronal-glia and inflammatory markers. Alterations in CHO are noted among individuals who remain impaired after 12 months of cART.
OBJECTIVE: Combination antiretroviral therapy (cART) can suppress plasma HIV RNA to undetectable levels; yet reports indicate persistent HIV-associated neurocognitive disorders (HAND) among treated individuals. We sought to investigate imaging correlates of incomplete cognitive recovery among individuals with chronic HIV. METHODS: We used single voxel proton magnetic resonance spectroscopy in 4 regions of the brain to measure changes in neuronal and glia biomarkers in cART-naive subjects before (n = 59, 27 with HAND) and after 12 months of cART. RESULTS: At baseline, we observed elevated total choline (CHO) in the basal ganglia (BG, P = 0.002) and in the posterior cingulate gyrus (PCG, P = 0.022) associated with HIV infection. Myo-inositol (MI) was elevated in the frontal white matter (FWM, P = 0.040). N-acetylaspartate was elevated in the BG (P = 0.047). Using a mixed model approach among all HIV-infected individuals, at 6 months, we observed decreased n- acetylaspartate in FWM (P = 0.031), decreased creatine in PCG (P = 0.026) and increased MI in frontal gray matter (FGM, P = 0.023). At 12 months, we observed an increase in BG MI (P = 0.038) and in FGM (P = 0.021). Compared to those with normal cognition, HAND cases had higher FGM MI (P = 0.014) at baseline. At 12 months, individuals that remained cognitively impaired compared with those without HAND exhibited elevated CHO in the PCG (P = 0.018) and decreased glutamate in both FWM (P = 0.027) and BG (P = 0.013). CONCLUSIONS: cART started during chronic HIV is associated with reduced neuronal-glia and inflammatory markers. Alterations in CHO are noted among individuals who remain impaired after 12 months of cART.
Authors: Alan Winston; Chris Duncombe; Patrick C K Li; John M Gill; Stephen J Kerr; Rebekah L Puls; Simon D Taylor-Robinson; Sean Emery; David A Cooper Journal: Neuroradiology Date: 2012-07-07 Impact factor: 2.804
Authors: Xue Hua; Christina P Boyle; Jaroslaw Harezlak; David F Tate; Constantin T Yiannoutsos; Ron Cohen; Giovanni Schifitto; Assawin Gongvatana; Jianhui Zhong; Tong Zhu; Michael J Taylor; Thomas B Campbell; Eric S Daar; Jeffry R Alger; Elyse Singer; Steve Buchthal; Arthur W Toga; Bradford Navia; Paul M Thompson Journal: Neuroimage Clin Date: 2013-08-03 Impact factor: 4.881
Authors: Robert A Fuller; Susan V Westmoreland; Eva Ratai; Jane B Greco; John P Kim; Margaret R Lentz; Julian He; Prabhat K Sehgal; Eliezer Masliah; Elkan Halpern; Andrew A Lackner; R Gilberto González Journal: BMC Neurosci Date: 2004-03-05 Impact factor: 3.288
Authors: Archana Asundi; Yvonne Robles; Tyler Starr; Alan Landay; Jennifer Kinslow; Joshua Ladner; Laura White; Rebeca M Plank; Kathleen Melbourne; Daniel Weisholtz; Monica Bennett; Hong Pan; Emily Stern; Alexander Lin; Daniel R Kuritzkes; Nina H Lin Journal: J Acquir Immune Defic Syndr Date: 2019-08-15 Impact factor: 3.731
Authors: Claudio Babiloni; Alfredo Pennica; Claudio Del Percio; Giuseppe Noce; Susanna Cordone; Susanna Lopez; Ketura Berry; Chiara Muratori; Stefano Ferracuti; Paolo Roma; Valentina Correr; Francesco Di Campli; Laura Gianserra; Lorenzo Ciullini; Antonio Aceti; Andrea Soricelli; Elisabetta Teti; Magdalena Viscione; Cristina Limatola; Paolo Onorati; Paolo Capotosto; Massimo Andreoni Journal: Neuroimage Clin Date: 2016-06-08 Impact factor: 4.881
Authors: Sophia Dahmani; Nicholas Kaliss; John W VanMeter; David J Moore; Ronald J Ellis; Xiong Jiang Journal: Neurology Date: 2021-07-12 Impact factor: 11.800